Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration.
Wang M, Zhang Z, Liu J, Song M, Zhang T, Chen Y, Hu H, Yang P, Li B, Song X, Pang J, Xing Y, Cao Z, Guo W, Yang H, Wang J, Yang J, Wang C.
Wang M, et al.
Signal Transduct Target Ther. 2022 May 13;7(1):157. doi: 10.1038/s41392-022-00959-3.
Signal Transduct Target Ther. 2022.
PMID: 35551173
Free PMC article.